Clinical Trial

Progress Update on Securities

HALIFAX, NS / ACCESSWIRE / August 30, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) has completed, with its Transfer Agent,…

9 months ago

Spencer Health Solutions Raises Series D to Expand Pharmaceutical and Care Management Markets

MORRISVILLE, N.C.--(BUSINESS WIRE)--Spencer Health Solutions, Inc., a pharma services and health technology company, announced today the successful close of its…

9 months ago

VitalPointTech Announces Acquisition of Herban Healing, LLC, a Revolutionary Bio-Pharmaceutical Company

Herban Healing is dedicated to providing alternative healthcare options to combat the opioid crisisHOUSTON, TX / ACCESSWIRE / August 29,…

9 months ago

Nova Mentis Announces Participant Screening Underway in Canada’s First Psilocybin Clinical Trial for Fragile X Syndrome

Vancouver, British Columbia--(Newsfile Corp. - August 30, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)…

10 months ago

The Science Times Publishes Article About Jaguar Health’s Focus on Developing Crofelemer for Two Rare Disease Indications

Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of short bowel syndrome and microvillus inclusion…

10 months ago

Veru to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 11th, 2023

MIAMI, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing…

10 months ago

Denali Therapeutics Announces New Interim Data from Phase 1/2 Study of DNL310 (ETV:IDS) in MPS II (Hunter Syndrome) at SSIEM 2023

Additional biomarker data up to two years of treatment continue to demonstrate rapid and sustained normalization of CSF heparan sulfate…

10 months ago

Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients

Claims covering inhibition of 3CL protease, inflammation and autophagy underscore Dr. Dorit Arad’s lifelong work NEW YORK, NY, ALPHARETTA, GA…

10 months ago

Marker Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

HOUSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation…

10 months ago

Cognition Therapeutics Announces Participation in Upcoming September Conferences

PURCHASE, N.Y., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage neuroscience company developing drugs that treat neurodegenerative…

10 months ago